...worker claimants and plan for the challenges that lay ahead. This edition of Rxinformer features in-depth articles and infographics on the latest trends and developments in workers’ comp, including: Cardiovascular...
...worker claimants and plan for the challenges that lay ahead. This edition of Rxinformer features in-depth articles and infographics on the latest trends and developments in workers’ comp, including: Cardiovascular...
...as common among workers who are members of a labor union. Workplace testing was the most common in the healthcare industry, with 48% of workers testing positive at least once....
...influence, leading to safety issues that could cause workplace injuries. For further information on marijuana’s impact on workers’ comp, download Healthesystems’ white paper, Clearing the Air: Marijuana Considerations for Workers’ Comp....
High-level trends in healthcare drug spending and utilization in workers? comp...
The Workers’ Compensation Research Institute (WCRI) published Interstate Variation and Trends in Workers’ Compensation Drug Payments: 2018Q1 to 2021Q1 —A WCRI FlashReport, which provides a high-level view of changing costs...
With the healthcare supply chain experiencing a multitude of disruptions, delays, shortages, and other concerns, an undeniable impact has been made on the delivery of workers’ comp products and services,...
...adjunct to opioid analgesics. Combogesic should be limited to five days of use or less. Combogesic features similar warnings that respectively come with acetaminophen and ibuprofen products. Acetaminophen can be...
...the differences between workers’ comp and group health PBMs and the specific value that workers’ comp PBMs bring to the table. Sandy Shtab was one of three panelists, joining Sean...
...tip of the iceberg when it comes to cyberattacks. Common threats facing organizations today include malware, denial-of-service attacks, phishing, and more. We spoke with Tony Brown, AVP, Information Security for...
...shortage due to increased demand, allowing compounders to formulate the drug. However, with the shortage declared over, compounders are now restricted from creating tirzepatide. Other GLP-1 drugs are still considered...
